PARAMETRIC PORTFOLIO ASSOCIATES LLC - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 271 filers reported holding QIAGEN NV in Q4 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of QIAGEN NV
ValueSharesWeighting
Q1 2022$42,950,000
-21.3%
876,522
-10.8%
0.02%
-17.9%
Q4 2021$54,593,000
+16.5%
982,238
+8.3%
0.03%
+3.7%
Q3 2021$46,881,000
+22.6%
907,132
+14.8%
0.03%
+28.6%
Q2 2021$38,230,000
-3.3%
790,200
-2.7%
0.02%
-8.7%
Q1 2021$39,549,000
-3.6%
812,259
+4.7%
0.02%
-11.5%
Q4 2020$41,006,000
+9.9%
775,896
+8.7%
0.03%
-3.7%
Q3 2020$37,313,000
+23.0%
713,996
+0.8%
0.03%
+17.4%
Q2 2020$30,337,000
-7.4%
708,641
-10.0%
0.02%
-23.3%
Q1 2020$32,767,000
+20.3%
787,670
-2.3%
0.03%
+50.0%
Q4 2019$27,247,000
-14.7%
806,131
-16.8%
0.02%
-23.1%
Q3 2019$31,935,000
-26.8%
968,614
-10.0%
0.03%
-27.8%
Q2 2019$43,645,000
-5.7%
1,076,315
-5.4%
0.04%
-10.0%
Q1 2019$46,277,000
+16.0%
1,137,581
-1.8%
0.04%0.0%
Q4 2018$39,897,000
-12.8%
1,158,105
-4.1%
0.04%0.0%
Q3 2018$45,731,000
+10.2%
1,207,254
+5.2%
0.04%
+2.6%
Q2 2018$41,507,000
+23.3%
1,147,863
+10.2%
0.04%
+18.2%
Q1 2018$33,655,000
+18.4%
1,041,641
+13.3%
0.03%
+17.9%
Q4 2017$28,433,000
+8.4%
919,268
+10.4%
0.03%0.0%
Q3 2017$26,225,000
+16.1%
832,524
+23.5%
0.03%
+3.7%
Q2 2017$22,598,000
+19.7%
673,954
+3.4%
0.03%
-6.9%
Q1 2017$18,884,000
+7.6%
651,832
+4.1%
0.03%
+20.8%
Q4 2016$17,548,000626,2500.02%
Other shareholders
QIAGEN NV shareholders Q4 2020
NameSharesValueWeighting ↓
Varenne Capital Partners 607,000$24,588,83923.75%
SYCOMORE ASSET MANAGEMENT 428,513$16,8664.32%
Nekton Capital Ltd. 614,940$24,905,0703.95%
Grandeur Peak Global Advisors, LLC 847,699$34,331,8102.58%
Southpoint Capital Advisors LP 1,500,000$60,750,0001.36%
Point72 Europe (London) LLP 468,364$18,968,7421.16%
SECTOR GAMMA AS 100,713$4,078,8771.04%
Susquehanna International Securities, Ltd. 28,711$1,162,7960.98%
Bank of Italy 651,125$26,3990.84%
PDT Partners, LLC 123,216$4,990,2480.63%
View complete list of QIAGEN NV shareholders